A look at how the Pfizer vaccine is performing in the real-world suggests it may not be as effective against the coronavirus variant that was first discovered in South Africa. A recently released ...
Newly released data from Pfizer/BioNTech’s ongoing study of their COVID-19 vaccine suggests it is effective at preventing serious symptoms and death at least six months after vaccination. The ...
NEW YORK (Reuters) – Pfizer Inc and BioNTech’s COVID-19 vaccine appeared to lose only a small bit of effectiveness against an engineered virus with three key mutations from the new coronavirus variant ...
JOHANNESBURG - The omicron variant appears to cause less severe disease than previous versions of the coronavirus, and the Pfizer vaccine seems to offer less defense against infection from it but ...
(Reuters) – South Africa halted the planned rollout of the COVID-19 vaccine developed by AstraZeneca and Oxford University after data showed it gave minimal protection against mild infection from one ...
New research suggests Pfizer’s COVID-19 vaccine can protect against a mutation found in the two more-contagious variants of the coronavirus that have erupted in Britain and South Africa. The study was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results